Last updated:
Author(s):
Brandon Lien, Varun Kasibhatla, Mariel Mawad, Jenee Anekwe, Joseph H. Friedman, Saud Alhusaini
Publish date:
18 December 2025
Journal:
Movement Disorders Clinical Practice
PubMed ID:
41410235

Abstract

BACKGROUND: Drug-induced Parkinsonism (DIP) is a predictor of future idiopathic Parkinson’s disease (PD), yet the prodromal characteristics of DIP remain unexplored.

OBJECTIVES: To compare prodromal peripheral immune cell profiles in DIP and PD.

METHODS: We applied independent regression models to evaluate the peripheral immune cell profiles in individuals with incident DIP (n = 108) and PD (n = 1055) relative to 20,070 healthy controls from the UK Biobank.

RESULTS: Approximately 9 years before diagnosis, both DIP and PD cases exhibited elevated neutrophil counts, neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII). Only PD cases showed reduced lymphocyte counts. After adjusting for psychiatric comorbidities, DIP-associated peripheral immune alterations were no longer significant.

CONCLUSIONS: The elevated neutrophil counts in DIP and PD suggest a shared innate immune system involvement. However, in DIP, the peripheral immune changes appear driven by psychiatric comorbidities, whereas lymphopenia may represent a distinctive prodromal biomarker of PD.

Related projects

This project will examine the relationship between the genetic risk factors for common neurological conditions, including Parkinson’s disease, essential tremor, and epilepsy, and brain structure…

Institution:
Rhode Island Hospital, United States of America

All projects